BackPardes Biosciences Overview

Pardes Biosciences Operating Income

Track Pardes Biosciences's operating income ($-85M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-10775000.00
↓ 61.84% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-84605000.00
↑ 12.09% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Pardes Biosciences (PRDS) FAQ

As of the most recent data (June 2023), PRDS shows a operating income of $-85M. That compares with $-75M in the prior-year period — down 12.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PRDS's operating income is now $-85M (was $-75M) — a 12.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pardes Biosciences is outperforming or lagging.

Tracking PRDS's operating income over time shows whether Pardes Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $-85M That compares with $-75M in the prior-year period — down 12.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Pardes Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-85M) with ownership activity and broader fundamentals.